These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 11046049)
1. Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells. Devito C; Broliden K; Kaul R; Svensson L; Johansen K; Kiama P; Kimani J; Lopalco L; Piconi S; Bwayo JJ; Plummer F; Clerici M; Hinkula J J Immunol; 2000 Nov; 165(9):5170-6. PubMed ID: 11046049 [TBL] [Abstract][Full Text] [Related]
2. Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers. Broliden K; Hinkula J; Devito C; Kiama P; Kimani J; Trabbatoni D; Bwayo JJ; Clerici M; Plummer F; Kaul R Immunol Lett; 2001 Nov; 79(1-2):29-36. PubMed ID: 11595287 [TBL] [Abstract][Full Text] [Related]
3. Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects. Devito C; Hinkula J; Kaul R; Kimani J; Kiama P; Lopalco L; Barass C; Piconi S; Trabattoni D; Bwayo JJ; Plummer F; Clerici M; Broliden K J Acquir Immune Defic Syndr; 2002 Aug; 30(4):413-20. PubMed ID: 12138348 [TBL] [Abstract][Full Text] [Related]
4. Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate. Devito C; Hinkula J; Kaul R; Lopalco L; Bwayo JJ; Plummer F; Clerici M; Broliden K AIDS; 2000 Sep; 14(13):1917-20. PubMed ID: 10997395 [TBL] [Abstract][Full Text] [Related]
5. Natural mucosal antibodies reactive with first extracellular loop of CCR5 inhibit HIV-1 transport across human epithelial cells. Bomsel M; Pastori C; Tudor D; Alberti C; Garcia S; Ferrari D; Lazzarin A; Lopalco L AIDS; 2007 Jan; 21(1):13-22. PubMed ID: 17148963 [TBL] [Abstract][Full Text] [Related]
6. Plasma and mucosal fluid from HIV type 1-infected patients but not from HIV type 1-exposed uninfected subjects prevent HIV type 1-exposed DC from infecting other target cells. Söderlund J; Hirbod T; Smed-Sörensen A; Johansson U; Kimani J; Plummer F; Spetz AL; Andersson J; Kaul R; Broliden K AIDS Res Hum Retroviruses; 2007 Jan; 23(1):101-6. PubMed ID: 17263639 [TBL] [Abstract][Full Text] [Related]
7. HIV-1 gp41-specific monoclonal mucosal IgAs derived from highly exposed but IgG-seronegative individuals block HIV-1 epithelial transcytosis and neutralize CD4(+) cell infection: an IgA gene and functional analysis. Tudor D; Derrien M; Diomede L; Drillet AS; Houimel M; Moog C; Reynes JM; Lopalco L; Bomsel M Mucosal Immunol; 2009 Sep; 2(5):412-26. PubMed ID: 19587640 [TBL] [Abstract][Full Text] [Related]
8. GP41-specific antibody blocks cell-free HIV type 1 transcytosis through human rectal mucosa and model colonic epithelium. Shen R; Drelichman ER; Bimczok D; Ochsenbauer C; Kappes JC; Cannon JA; Tudor D; Bomsel M; Smythies LE; Smith PD J Immunol; 2010 Apr; 184(7):3648-55. PubMed ID: 20208001 [TBL] [Abstract][Full Text] [Related]
9. Cervicovaginal HIV-1-neutralizing immunoglobulin A detected among HIV-1-exposed seronegative female partners in HIV-1-discordant couples. Choi RY; Levinson P; Guthrie BL; Lohman-Payne B; Bosire R; Liu AY; Hirbod T; Kiarie J; Overbaugh J; John-Stewart G; Broliden K; Farquhar C AIDS; 2012 Nov; 26(17):2155-63. PubMed ID: 22948273 [TBL] [Abstract][Full Text] [Related]
10. HIV-neutralizing immunoglobulin A and HIV-specific proliferation are independently associated with reduced HIV acquisition in Kenyan sex workers. Hirbod T; Kaul R; Reichard C; Kimani J; Ngugi E; Bwayo JJ; Nagelkerke N; Hasselrot K; Li B; Moses S; ; MacDonald KS; Broliden K AIDS; 2008 Mar; 22(6):727-35. PubMed ID: 18356602 [TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus (HIV)-specific IgA and HIV neutralizing activity in the serum of exposed seronegative partners of HIV-seropositive persons. Mazzoli S; Lopalco L; Salvi A; Trabattoni D; Lo Caputo S; Semplici F; Biasin M; Bl C; Cosma A; Pastori C; Meacci F; Mazzotta F; Villa ML; Siccardi AG; Clerici M J Infect Dis; 1999 Sep; 180(3):871-5. PubMed ID: 10438383 [TBL] [Abstract][Full Text] [Related]
12. Infectious human immunodeficiency virus can rapidly penetrate a tight human epithelial barrier by transcytosis in a process impaired by mucosal immunoglobulins. Hocini H; Bomsel M J Infect Dis; 1999 May; 179 Suppl 3():S448-53. PubMed ID: 10099117 [TBL] [Abstract][Full Text] [Related]
13. Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A. Wright A; Lamm ME; Huang YT J Virol; 2008 Dec; 82(23):11526-35. PubMed ID: 18829757 [TBL] [Abstract][Full Text] [Related]
14. Epidemiologic and biologic characterization of a cohort of human immunodeficiency virus type 1 highly exposed, persistently seronegative female sex workers in northern Thailand. Chiang Mai HEPS Working Group. Beyrer C; Artenstein AW; Rugpao S; Stephens H; VanCott TC; Robb ML; Rinkaew M; Birx DL; Khamboonruang C; Zimmerman PA; Nelson KE; Natpratan C J Infect Dis; 1999 Jan; 179(1):59-67. PubMed ID: 9841823 [TBL] [Abstract][Full Text] [Related]
15. Gender dimorphism in the gut: mucosal protection by estrogen stimulation of IgA transcytosis. Diebel ME; Diebel LN; Liberati DM J Trauma; 2011 Aug; 71(2):474-9. PubMed ID: 21825949 [TBL] [Abstract][Full Text] [Related]
16. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells. Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650 [TBL] [Abstract][Full Text] [Related]
17. Intraepithelial cell neutralization of HIV-1 replication by IgA. Huang YT; Wright A; Gao X; Kulick L; Yan H; Lamm ME J Immunol; 2005 Apr; 174(8):4828-35. PubMed ID: 15814709 [TBL] [Abstract][Full Text] [Related]
19. Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8. Yu X; Duval M; Lewis C; Gawron MA; Wang R; Posner MR; Cavacini LA J Immunol; 2013 Jan; 190(1):205-10. PubMed ID: 23183895 [TBL] [Abstract][Full Text] [Related]
20. Cervicovaginal secretory antibodies to human immunodeficiency virus type 1 (HIV-1) that block viral transcytosis through tight epithelial barriers in highly exposed HIV-1-seronegative African women. Bélec L; Ghys PD; Hocini H; Nkengasong JN; Tranchot-Diallo J; Diallo MO; Ettiègne-Traore V; Maurice C; Becquart P; Matta M; Si-Mohamed A; Chomont N; Coulibaly IM; Wiktor SZ; Kazatchkine MD J Infect Dis; 2001 Dec; 184(11):1412-22. PubMed ID: 11709783 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]